Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Int. braz. j. urol ; 43(5): 857-862, Sept.-Oct. 2017. tab, graf
Article in English | LILACS | ID: biblio-892899

ABSTRACT

ABSTRACT Purpose: To assess and report the outcomes of laparoscopic partial nephrectomy) LPN) for T2 renal masses. Materials and Methods: Retrospective review of patients undergoing LPN for clinically localized renal masses ≥7cm between the years 2005-2016. Descriptive analyses were generated for demographics, lesion characteristics, perioperative variables (operative time, warm ischemia time (WIT), estimated blood loss (EBL), intra-operative and postoperative complications (IOC and POC) and pathologic variables (pathology, subtype and Fuhrman grade). Results: A total of 27 patients underwent LPN for a T2 renal mass at our institution between 2005 and early 2016 of which 19 were males. The mean age was 66 (52-72). All procedures were transperitoneal with 16 on the right and 11 on the left. Median operative time was 200 minutes (IQR 181-236) and median WIT 19 minutes (IQR 16-23). EBL was 125mL (IQR 75-175). One case was converted to laparoscopic radical nephrectomy due to suspected tumor thrombus in the renal vein. Surgical margins were positive in one renal tumor in a patient with multiple tumors. There was a total of 2 IOC (7.4%) and 3 POC (11%) classified as Clavien grade 3. Conclusions: To our knowledge, this series is the first to describe the outcomes of LPN for cT2 renal masses. In our series, LPN for larger renal masses appears feasible with favorable perioperative outcomes. Additional data are needed to further explore the benefits of minimally invasive surgical approaches to larger renal masses.


Subject(s)
Humans , Male , Female , Adult , Laparoscopy/methods , Tumor Burden , Kidney Neoplasms/surgery , Kidney Neoplasms/pathology , Nephrectomy/methods , Retrospective Studies , Treatment Outcome , Perioperative Care , Middle Aged , Neoplasm Staging
2.
Journal of Periodontal & Implant Science ; : 251-261, 2013.
Article in English | WPRIM | ID: wpr-173295

ABSTRACT

A paradigm shift is taking place in medicine and dentistry from using synthetic implants and tissue grafts to a tissue engineering approach that uses degradable porous three-dimensional (3D) material hydrogels integrated with cells and bioactive factors to regenerate tissues such as dental bone and other oral tissues. Hydrogels have been established as a biomaterial of choice for many years, as they offer diverse properties that make them ideal in regenerative medicine, including dental applications. Being highly biocompatible and similar to native extracellular matrix, hydrogels have emerged as ideal candidates in the design of 3D scaffolds for tissue regeneration and drug delivery applications. However, precise control over hydrogel properties, such as porosity, pore size, and pore interconnectivity, remains a challenge. Traditional techniques for creating conventional crosslinked polymers have demonstrated limited success in the formation of hydrogels with large pore size, thus limiting cellular infiltration, tissue ingrowth, vascularization, and matrix mineralization (in the case of bone) of tissue-engineered constructs. Emerging technologies have demonstrated the ability to control microarchitectural features in hydrogels such as the creation of large pore size, porosity, and pore interconnectivity, thus allowing the creation of engineered hydrogel scaffolds with a structure and function closely mimicking native tissues. In this review, we explore the various technologies available for the preparation of macroporous scaffolds and their potential applications.


Subject(s)
Dentistry , Extracellular Matrix , Hydrogels , Hydrogels , Polymers , Porosity , Regeneration , Regenerative Medicine , Tissue Engineering , Transplants
3.
Folha méd ; 98(3): 163-7, mar. 1989. tab
Article in Portuguese | LILACS | ID: lil-69093

ABSTRACT

Trinta pacientes portadores de artrite reumatóide foram aditidos em um estudo duplo-cego em grupos paralelos, comparando tenoxicam 20 mg com piroxicam 20 mg. Ambos os grupos eram estatisticamente comparáveis quanto a sexo, idade, testes laboratoriais e parâmetros clínicos. Após o tratamento todos os parâmetros estudados revelaram melhora estatisticamente significativa nos dois grupos, com respeito aos parâmetros clínicos e avaliaçäo final da eficácia. Observou-se, porém, uma tendência clínica favorável ao tenoxicam em todos os parâmetros estudados


Subject(s)
Humans , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Rheumatoid/drug therapy , Piroxicam/therapeutic use , Clinical Trials as Topic , Double-Blind Method
SELECTION OF CITATIONS
SEARCH DETAIL